Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults
Is a
Allocation Type
Randomized
0
Intervention Model
Parallel Assignment
0
Intervention Name
VXA-A1.1 H1 Tablet Vaccine (small)
0
VXA-A1.1 H1 Tablet Vaccine (large)
0
Interventional Trial Phase
Phase 1
0
Interventional Trial Purpose
Other
0
Intervention Type
Biological
0
Last Updated
May 30, 2018
0
Masking Type
None (Open Label)
0
Primary Completion Date
May 5, 2017
0
Trial Recruitment Size
8
0
Trial Sponsor
Clinical Trial Start Date
March 31, 2017
0
Study Completion Date
April 3, 2018
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase 1, Open-Label, Randomized, 2×2 Crossover Study of Pharmacodynamics Comparing the Impact of Tablet Size and Fasting Status With an Oral Human Influenza A/California/04/2009 (H1N1) HA Adenoviral-Vector Based Vaccine and dsRNA Adjuvant
0
Official Website
Find more entities like Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.